News for 'Merck KGaA'

Ranbaxy bids for Merck's generic unit

India's biggest drug maker Ranbaxy Laboratories Ltd has put in its bid to acquire generic business of German pharmaceutical firm Merck.

Merck eyes Indian drug biggie, brands

Germany-based Merck KGaA, the world's oldest multinational pharmaceutical company, is eyeing to acquire a prominent Indian pharmaceutical company and established drug brands.

Glenmark licenses diabetes drug to Merck

Merck to conduct cancer vaccine trials in India

Ranbaxy to bid for $2.3 bn Merck arm

The Indian major is eyeing German Merck's generic drug business.

Pharma MNCs plan subsidiaries in India

'India is a growth story for us'

Karl-Ludwig Kley, chairman of the executive board, Merck, spoke to Business Standard about the company's plans and how it is weathering the global financial crisis.

Prices of 52 more 'essential' drugs capped

The new drugs to come under price control include commonly-used antibiotics and painkillers

Ranbaxy on an acquisition spree

Having cut eight deals last year, the $1.3 billion pharma major Ranbaxy probably has the sharpest negotiating skills in the business.

EU regulators to fine drug makers including Ranbaxy

European regulators have estimated that consumers are paying up to 20 per cent more for medicines in some cases.

European Commission fines 9 pharma firms, including Ranbaxy

According to information available on the European Commission website, Ranbaxy Laboratories has been fined euro 10.32 million (over Rs 80 crore).